← All Ibio, INC filings

Ibio, INC Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NASDAQ
IBIO
Ibio, INC
Form 4: iBio Executive Receives Stock Grant
Molly Carr, Chief Medical Officer of iBio, Inc., received 430,000 shares of common stock on July 31, 2026.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Acquires Stock Options
iBio, Inc. reports that Director Elizabeth Stoner acquired 60,000 stock options with an exercise price of $1.42, vesting over 36 months.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Chief Legal Officer Boosts Stake with Share Purchase
iBio's Chief Legal Officer, Marc Banjak, increased his direct ownership in the company by purchasing 13,934 shares of common stock.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CFO Boosts Stake with 24,835 Share Purchase
iBio's Chief Financial Officer, Felipe Duran, reported the purchase of 24,835 shares of common stock on March 19, 2026, increasing his direct beneficial ownership.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CEO Martin Brenner Buys 12,336 Shares
iBio's CEO and Chief Scientific Officer, Martin Brenner, acquired 12,336 shares of common stock at $2.02 per share.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Chief Legal Officer Granted 146,000 Stock Options
iBio's Chief Legal Officer, Marc Banjak, was granted 146,000 stock options with an exercise price of $2.23, vesting over four years.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CFO Granted 179,000 Stock Options
iBio, Inc.'s Chief Financial Officer, Felipe Duran, was granted 179,000 stock options with an exercise price of $2.23.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CEO Martin Brenner Granted 479,000 Stock Options
iBio, Inc. disclosed that CEO and Chief Scientific Officer Martin Brenner was granted 479,000 stock options with an exercise price of $2.23, vesting over four years.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Gary Sender Acquires Stock Options
iBio Director Gary Sender acquired 13,500 stock options with an exercise price of $1, vesting monthly over twelve months.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Granted 13,500 Stock Options
iBio, Inc. Director Evert B. Schimmelpennink was granted 13,500 stock options with an exercise price of $1, vesting monthly over twelve months.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Granted 13,500 Stock Options
iBio, Inc. Director William D. Clark received a grant of 13,500 stock options with an exercise price of $1, vesting monthly over twelve months.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Granted 13,500 Stock Options
iBio, Inc. director Alexandra Kropotova was granted 13,500 stock options with an exercise price of $1, aligning her interests with shareholders.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Granted 13,500 Stock Options
iBio, Inc. Director Antonio Bernardino Guimaraes Parada was granted 13,500 stock options with a $1 exercise price, vesting monthly over twelve months.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Arkowitz Granted 13,500 Stock Options
iBio Director David Arkowitz received a grant of 13,500 stock options with an exercise price of $1, vesting monthly over 12 months.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CFO Acquires 75,000 Stock Options
iBio, Inc.'s Chief Financial Officer, Felipe Duran, has acquired 75,000 stock options with an exercise price of $0.893, vesting over four years.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CLO Marc Banjak Granted 55,000 Stock Options
iBio's Chief Legal Officer, Marc Banjak, was granted 55,000 stock options with an exercise price of $0.893, vesting over four years.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CEO Martin Brenner Awarded Stock Options
iBio, Inc. CEO and Chief Scientific Officer Martin Brenner was granted 180,000 stock options with an exercise price of $0.893.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Inc. Chief Legal Officer Marc Banjak Reports Stock Option Grant
iBio, Inc.'s Chief Legal Officer, Marc Banjak, reported the grant of stock options in a recent SEC Form 4 filing.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CFO Felipe Duran Reports Stock Option Grant
Felipe Duran, CFO of iBio, Inc., reports the acquisition of stock options.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CEO Martin Brenner Acquires 230,700 Stock Options
iBio's CEO, Martin Brenner, reports the acquisition of 230,700 stock options in the company.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio CFO Felipe Duran Reports Acquisition of Shares
Felipe Duran, CFO of iBio, Inc., reports purchasing shares of common stock on January 10, 2025.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Brenner Acquires Shares in Recent Transaction
Director and Officer Martin Brenner reports acquisition of iBio, Inc. shares via a Securities Purchase Agreement.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Chief Legal Officer Marc Banjak Reports Stock Purchase
Marc Banjak, Chief Legal Officer of iBio, Inc., reports purchasing shares of common stock on January 10, 2025.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director David Arkowitz Reports Purchase of 18,382 Shares
Director David Arkowitz reports purchasing 18,382 shares of iBio, Inc. at $2.72 per share on January 10, 2025.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director William D. Clark Acquires Shares in Recent Transaction
Director William D. Clark purchased 1,838 shares of iBio, Inc. common stock at a price of $2.72 per share on January 10, 2025.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Parada Acquires 183,823 Shares Through MagicRoad SGPS
Antonio Bernardino Guimaraes Parada, a director of iBio, Inc., acquired 183,823 shares of common stock through MagicRoad SGPS, Unipessoal LDA on January 10, 2025.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Gary Sender Acquires Shares in Open Market Transaction
Director Gary Sender purchased 9,191 shares of iBio, Inc. common stock at $2.72 per share on January 10, 2025.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Acquires 12,600 Stock Options in Recent Transaction
iBio director Antonio Bernardino Guimaraes Parada acquired 12,600 stock options at an exercise price of $2.45, vesting over three years.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Gary Sender Acquires 18,900 Stock Options
iBio director Gary Sender acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.
NASDAQ
IBIO
Ibio, INC
Form 4: iBio Director Acquires Stock Options in Recent Transaction
iBio director Evert B. Schimmelpennink acquired 18,900 stock options on November 21, 2024, which vest monthly over twelve months.